antineoplastic monoclonal antibody
Jump to navigation
Jump to search
Introduction
A mononclonal antibody used to treat malignant neoplasm(s)
More general terms
More specific terms
- alemtuzumab (Campath-1H, Lemtrada)
- amivantamab (Rybrevant)
- atezolizumab (Tecentriq)
- avelumab (Bavencio)
- belantamab mafodotin-blmf (Blenrep)
- bevacizumab (Avastin, Altuzan)
- blinatumomab (Blincyto)
- camrelizumab
- cemiplimab (Libtayo)
- cetuximab (Erbitux)
- daratumumab (Darzalex)
- dinutuximab (Unituxin)
- dostarlimab-gxly (JEMPERLI)
- durvalumab (Imfinzi)
- elotuzumab (Empliciti)
- elranatamab-bcmm (Elrexfio)
- enfortumab vedotin (Padcev)
- epcoritamab-bysb (Epkinly)
- flotetuzumab
- gemtuzumab ozogamicin (Mylotarg)
- glofitamab-gxbm (Columvi)
- ibritumomab tiuxetan
- inotuzumab ozogamicin (Besponsa)
- ipilimumab (Yervoy)
- isatuximab isatuximab-irfc (Sarclisa)
- loncastuximab tesirine-lpyl (Zynlonta)
- margetuximab
- mirvetuximab soravtansine-gynx (Elahere)
- mogamulizumab-kpkc (Poteligeo)
- mosunetuzumab-axgb (Lunsumio)
- moxetumomab pasudotox (Lumoxiti)
- naxitamab-gqgk (Danyelza)
- necitumumab (Portrazza)
- nivolumab (Opdivo)
- obinutuzumab (Gazyva)
- ofatumumab (Arzerra, Kesimpta)
- olaratumab (Lartruvo)
- panitumumab (Vectibix)
- pembrolizumab (Keytruda)
- pertuzumab (Perjeta)
- ranibizumab (Lucentis, Byooviz)
- retifanlimab (Zynyz)
- rituximab (Rituxan, Mabthera, Truxima, Ruxience, Riabni)
- sacituzumab govitecan-hziy (Trodelvy)
- sugemalimab
- talquetamab
- tarlatamab (AMG 757)
- teclistamab-cqyv (Tecvayli)
- tislelizumab
- toripalimab-tpzi (Loqtorzi)
- tositumomab (Bexxar)
- trastuzumab (Herceptin, Herzuma, CT-P6)
- tremelimumab (Imjudo)